Clinical Trial Update: XC8 in the Treatment of Patients With Acute Respiratory Viral Infection [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicates the Phase 2 and Phase 3 studies of XC8 for acute respiratory viral infection have been completed; specific results are not provi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Infection

Drugs mentioned

• XC8

Snippet

Sponsor: PHARMENTERPRISES LLC | Conditions: Influenza, Acute Respiratory Infection | Phase 2, Phase 3 | Status: COMPLETED